US Courts
Novartis’ subsidiary Sandoz agrees to pay $195 million to settle antitrust case
March 3, 2020Manufacturing and Production Novartis, US Courts, generic drugs, generics, price fixing, price-fixing
Novartis’ Sandoz will pay a $195 million criminal penalty to resolve charges that it conspired to price-fix, rig bids and …
